Buehlmann


/

A commitment to diagnostics

Success StorySuccess StorySuccess StorySuccess StorySuccess Story

Presentation of BÜHLMANN Calprotectin assays and applications.

Successful Introduction of Quantum Blue Routine Application in the UK at the Royal Berkshire Hospital, Reading

The sleep clinic in Zurzach/Luzern, Switzerland started with the Sleep Check Concept under the name of Melatonin-Check for the assessment of DLMO to diagnose circadian rhythm disorders.

Lars Abrahamsson, manager responsible for the drug of abuse laboratory, Trollhättan, Sweden, has successfully evaluated and introduced into routine work the new BÜHLMANN enzymatic GHB assay.

Evaluation of the most important Pharmacogenetics tests

Read the impressions of the University Hospital in Geneva
Dr. Michela Rebsamen from the labaratory medicine department at the University Hospital in Geneva (HUG) did an evaluation study of the most important tests in pharmacogenetics (CYP2D6, CYP2C19, CYP2C9-VKORC1 and MDR1) on the INFINITI® Analyser.


Dossier

Calprotectin Assay Application

The published evidence for the clinical validity of the calprotectin ELISA and Quantum Blue® more

Dossier

GHB - Cheap dope or bummer?

GHB well known as Liquid Ecstasy und Liquid X is voluntarily consumed not only by partygoers. more


Events
Assises Nationales des MICI 2015
23 janvier 2015 | 8èmes Assises Nationales des MICI, Paris, France.
Arab Health 2015
26 - 29 January 2015 | Arab Health, Dubai International Convention & Exhibiton Centre, United Arab Emirates.Visit us at booth #RG12 in Sheikh Rashid Hall.
ECCO 2015
18 - 21 February 2015 | Inflammatory Bowel Diseases 2015 – 10th Congress of ECCO, Barcelona, Spain. Visit us at booth #18.

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Distributors
Order
About us
Job opportunities

News

BÜHLMANN presents www.ibdoc.net

BÜHLMANN launched www.ibdoc.net at this year's UEGW in Vienna. This new website serves as a platform to inform a broad audience about the BÜHLMANN Calprot  more

Evaluation of the QUIDEL AmpliVue® C.difficile MDx POC system at MCL, Niederwangen

Interview with the leader of this evaluation study, Dr. Angelika Ströhle about her positive experiences with this new rapid MDx testing system to detect t  more

Movie from Quidel showing how quick and easy the AmpliVue C. difficile MDx test can be performed, without the need of expensive equipment.

Watch this movie from Quidel to see how simple the AmpliVue® C. difficile MDx test can be performed in only 80 minutes, with Hands-On time of < 10 minut  more

Market Launch of CALEX Device

BÜHLMANN announces the launch and introduction of the brand new stool extraction device CALEX® Cap. The features of the CALEX® extraction tool are unique  more

Get our RSS - Feed

Web Statistics